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Background: Approximately 70% of US adults currently receiving opioid agonist 
treatment (OAT) for opioid use disorder are of reproductive age. Among women receiving 
OAT at risk of having an unintended pregnancy, typically less than half report any current 
contraceptive use compared to 90% in the general population. In addition, the rate of 
unintended pregnancy among women receiving OAT is disproportionately higher than the 
general population (~80% vs. 45%, respectively). Lack of knowledge about family 
planning may be contributing to decreased rates of contraceptive use and increased rates 
of unintended pregnancy among women receiving OAT. 
Method: Participants were a convenience sample of women and men receiving OAT or a 
comparison group receiving primary care (PC) services. Family planning knowledge was 
assessed with the recently validated Contraceptive Knowledge Assessment (CKA), a self-
administered 25-question multiple-choice survey. A two-way ANOVA, with fixed factors 
(i.e. patient sample and sex), compared the total number of correct responses for all 
questions and five more specific content areas (p<.05).  
Results: Overall, 332 participants completed this survey. The mean percent of total correct 
responses was significantly lower in the OAT sample (n=167) compared to the PC sample 
(n=165), 47% vs. 53% correct, respectively (p<.001) or approximately 1.5 questions less. 
The mean percent of correct responses in four of the five content areas was also lower 
among the OAT sample compared to the PC sample (ps<.01). The mean percent of total 
correct responses was significantly higher among women  (n=169) than men (n=163), 56% 
vs. 44% correct, respectively (p<.0001) or approximately 3 questions more.  The percent 
of correct responses in four of the five content areas was also higher among women than 
men (ps<.01). 
Conclusion: Given the substantial discrepancy in rates of contraceptive use and 
unintended pregnancy between individuals receiving OAT and the general population, it 
is somewhat unexpected that individuals receiving OAT did not have lower levels of 
family planning knowledge, although patients in both samples only answered 
approximately 50% of the questions correctly. Results from the present study suggest 
deficits in family planning knowledge, while statistically significant, may be less 
clinically so.   Overall, lack of family planning knowledge is likely only playing a small 
role in population differences in contraceptive use and unintended pregnancy and 
interventions aimed at decreasing these differences will need to address other barriers to 
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During the past several decades, significant advances in pharmacology and the 
classification of pain as the “5th” vital sign have led to the exponential growth in the use of 
prescription opioid medications (e.g. oxycodone, fentanyl) to treat and manage pain. This 
proliferation has contributed to alarming rates of misuse of opioid medications, heroin use, 
and the prevalence of overdose deaths which preempted the US Department of Health and 
Human Services to declare the opioid crisis a nationwide Public Health Emergency in 2017 
(Center for Behavioral Health Statistics and Quality, 2018; Hedegaard, Warner, & Minino, 
2017; Martins et al., 2017; US Department of Health and Human Services, 2017).  
Approximately 66% of the more than 11 million individuals who reported misuse of 
opioids (i.e. misuse of prescription opioid medication and/or heroin use) during the past 
year are women and men of reproductive age (15-45 years old; Center for Behavioral 
Health Statistics and Quality, 2018). Most alarmingly, between 1999 and 2017, the rate of 
opioid-related overdose deaths increased more than 500% for individuals of reproductive 
age (Centers for Disease Control and Prevention, 2019a).  
 
A Note about Terminology and Classification  
 Before continuing, it is important to briefly review terminology associated with 
descriptions of opioid misuse and treatment, as there have been many changes in recent 
years.  Prior to 2013, the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
described maladaptive patterns of opioid use, both nonmedical use of prescription opioid 







the DSM was published in 2013 (DSM-5), substance use-related diagnostic criteria, 
including opioid use, changed significantly. The DSM-5 combined abuse and dependence 
into a single category and measures severity of use on a continuum (American Psychiatric 
Association, 2013). These changes represent a major paradigm shift in how opioid and 
other substance use disorders are conceptualized (i.e. a chronic, relapsing disease). This 
diagnostic reclassification has also resulted in ongoing changes to the terminology used to 
describe opioid misuse. Professional organizations including the American Medical 
Association and the American Society of Addiction Medicine have endorsed the use of 
phrases such as nonmedical use of opioids, individuals with opioid use disorder (OUD), 
medication treatment for OUD (i.e. methadone, buprenorphine, naloxone), and opioid 
agonist treatment (OAT; i.e. methadone or buprenorphine) and recommend the 
abandonment of terms like addict, abuse, replacement therapy, and substitution treatment 
(American Society of Addiction Medicine, 2015; Olsen & Sharfstein, 2014; Substance 
Abuse and Mental Health Services Administration, 2015). Using appropriate language to 
describe opioid misuse supports reduction of stigma, prejudice, and judgment. However, 
from a research perspective, variations in language and classification criteria over the years 
create methodological issues in terms of comparing studies and making inferences about 
study outcomes.  For the purposes of this study, contemporary language will be used as 
much as possible to describe this population and prior research outcomes. 
 
Opioid Misuse and Unintended Pregnancy 
 Approximately 70% of US adults currently receiving OAT are of reproductive age 







misuse negatively impacts both women and men (Rudd, Aleshire, Zibbell, & Matthew 
Gladden, 2016; Seth, Rudd, Noonan, & Haegerich, 2018; Whiteman et al., 2014; 
Winkelman, Chang, & Binswanger, 2018),  reproductive-age women can be affected in 
unique ways (see review by Back, Lawson, Singleton, & Brady, 2011; Jarlenski et al., 
2017; Jones, Tuten, Keyser-Marcus, & Svikis, 2006; Kozhimannil, Graves, Jarlenski, et 
al., 2017). One way that has historically received relatively little attention is the high rate 
of unintended pregnancy in this population. Unintended pregnancy is a broader term that 
collectively refers to pregnancies that are mistimed (i.e. occurring earlier than the woman 
desired) or unwanted (i.e. occurring even though the woman did not desire it) (Santelli et 
al., 2003).  
The health implications of planning a pregnancy are significant. Women who do 
not plan their pregnancies are less likely to engage in health-promoting behaviors during 
the preconception and perinatal periods compared to women with intended pregnancies 
(Cheng et al., 2016; Dott et al., 2010; Orr, James, & Reiter, 2008; Rassi, Wattimena, & 
Black, 2013). For example, unintended pregnancies are associated with delayed prenatal 
care (Cheng, Schwarz, Douglas, & Horon, 2009; Lindberg, Maddow-Zimet, Kost, & 
Lincoln, 2015) and decreased use of prenatal vitamins (Dott et al., 2010). Women who 
report having an unintended pregnancy are also less likely to initiate and continue 
breastfeeding compared to women who plan their pregnancies (Lindberg et al., 2015) and 
prenatal and postpartum maternal depression are more prevalent (Abajobir, Maravilla, 
Alati, & Najman, 2016; Cheng et al., 2009; Fellenzer & Cibula, 2014; McCrory & 







In the first large-scale estimate of the prevalence of unintended pregnancy among 
pregnant women reporting recent opioid misuse, pregnancy intention was assessed in 
approximately 1000 pregnant women screened for enrollment in the MOTHER study, a 
multi-site randomized, controlled trial comparing OAT (i.e. methadone versus 
buprenorphine) for the treatment of opioid misuse during pregnancy (Heil et al., 2011). 
Results indicated that almost 9 of every 10 pregnancies were unintended (86%).  This is in 
striking contrast to women in the general population who report 45% of their pregnancies 
are unintended (Finer & Zolna, 2016). Subsequent studies with women receiving OAT 
have consistently reported results similar to the Heil et al. (2011) study, with the rate of 
unintended pregnancy averaging nearly 80% across reports (Black, Stephens, Haber, & 
Lintzeris, 2012; Fischbein et al., 2018; Kreitinger et al., 2016; Meschke, McNeely, Brown, 
& Prather, 2018; Smith, Morse, & Busby, 2019; Welle-Strand et al., 2013, 2015). 
 
Opioid Misuse and Pregnancy  
Prevalence. Increasing rates of opioid misuse among women of reproductive age 
coupled with high rates of unintended pregnancy have inevitably led to increases in opioid 
misuse by pregnant women. Rates of opioid misuse have, not surprisingly, also contributed 
to the high prevalence of OUD during pregnancy and the subsequent need for treatment 
(Kozhimannil, Graves, Levy, & Patrick, 2017; see review by Krans & Patrick, 2016; Metz, 
Brown, Martins, & Palamar, 2018; Pan & Yi, 2013). Nationally, it is estimated that the 
prevalence of maternal OUD at hospital delivery has more than quadrupled from 1999 to 







 Consequences. Opioid misuse during pregnancy even among women receiving 
OAT, is often compounded by a multitude of factors, such as other drug use (Davie-Gray, 
Moor, Spencer, & Woodward, 2013), poor prenatal care (Parlier, Fagan, Ramage, & 
Galvin, 2014; Roberts & Pies, 2011), psychiatric symptoms (Benningfield et al., 2012; 
Whiteman et al., 2014), and low socioeconomic status (SES; Corr & Hollenbeak, 2017; 
Hand, Short, & Abatemarco, 2017; Martin, Longinaker, & Terplan, 2015), that collectively 
contribute to adverse consequences for the infant, including premature delivery and low 
infant birth weight (Metz et al., 2018; Patrick et al., 2015; Saia et al., 2017; Yazdy, Desai, 
& Brogly, 2015). In addition, infants exposed to opioids in utero may develop neonatal 
abstinence syndrome (NAS), a generalized disorder characterized by signs of central 
nervous system hyperirritability, gastrointestinal dysfunction, respiratory distress, and 
autonomic dysregulation (Finnegan, Connaughton, Kron, & Emich, 1975), that often 
requires extended hospitalization (typically 4 days) for monitoring and treatment (see 
review by Bagley, Wachman, Holland, & Brogly, 2014; Jones et al., 2010; Kelty & Hulse, 
2017; Patrick, Kaplan, Passarella, Davis, & Lorch, 2014; Patrick et al., 2016; Substance 
Abuse and Mental Health Services Administration, 2018; Tolia et al., 2015). Not 
surprisingly, as maternal OUD has increased, so has the number of infants diagnosed with 
NAS. For example, between 2004 to 2014, the national incidence of NAS increased more 
than five-fold, from 1.5 to 8.0 per 1000 hospital births (Winkelman, Villapiano, 
Kozhimannil, Davis, & Patrick, 2018). In addition, poor birth outcomes and prolonged 
monitoring and treatment add significantly to acute medical costs. It is estimated that 
aggregate hospital charges for NAS treatment were approximately $1.5 billion/year in 2012 







Cooper, 2015). The most recent estimates suggest the costs of hospital admission for an 
infant with NAS are more than 2.5 times greater than that for an infant without NAS (Corr 
& Hollenbeak, 2017). 
 More generally and longer term, bearing a child in disadvantaged circumstances 
like those of many women receiving OAT significantly diminishes the future wellbeing of 
both the mother and the child. For a woman growing up in circumstances of lower SES, 
the frequent occurrence of early motherhood and single motherhood increase the risk of 
persistent disadvantage for her but also for her children, while a woman from a higher SES 
background is more likely to postpone cohabitation and parenthood and thereby maintain 
a higher SES (Tough, Vekved, & Newburn-Cook, 2012).  Overall, unintended pregnancy 
among women receiving OAT is associated with significant short- and long-term 
consequences of extraordinary cost for both mother and child.   
 
Family Planning 
 The purpose of family planning is to support women and their male partners in 
achieving the number and spacing of children they desire (Gavin & Moskosky, 2014). 
Family planning includes information about fertility awareness, contraceptive services, 
pregnancy testing and counseling, basic infertility services, sexually transmitted infection 
(STI) services and other preconception and preventive health services (Gavin et al., 2014).  
As the average woman spends about three decades of her life trying to avoid unintended 
pregnancy (Sonfield, Hasstedt, & Gold, 2014), the overwhelming majority of family 







Fertility awareness. Recognizing and understanding a woman’s fertility is an 
important component of family planning because it maximizes a woman’s (or couple’s) 
control of whether and when to have children (Gavin et al., 2014). The only time a woman 
can become pregnant is during ovulation, colloquially referred to as the “fertile window” 
of the menstrual cycle. Consequently, many women/couples time intercourse and 
determine whether or not to use contraception based on the status of the woman’s menstrual 
cycle (Lundsberg et al., 2014; Mosher, Jones, & Abma, 2015; Nettleman, Chung, Brewer, 
Ayoola, & Reed, 2007; Pallone & Bergus, 2009; Righarts, Dickson, Parkin, & Gillett, 
2017; Smoley & Robinson, 2012). However, these strategies can be problematic if fertility 
awareness and other knowledge about the biological processes of conception (e.g. how 
long sperm survive) are inaccurate. Women with OUD, even those receiving OAT, often 
report lower perceived risk of becoming pregnant because of opioid use (Harding & 
Ritchie, 2003; Olsen, Banwell, & Madden, 2014), but little is known about their fertility 
awareness or whether it is associated with their contraceptive use. 
Contraceptive services. Contraceptive services revolve primarily around 
contraceptive methods. There are many different contraceptive methods with varying 
levels of effectiveness currently available in the US, the majority of which need to be 
prescribed by qualified healthcare providers.  Most contraceptive methods are for use by 
women, but at least two methods (i.e. male sterilization and male condoms) are for men 
(Curtis, Tepper, et al., 2016). Female and male sterilization are highly effective methods 









prevention within the first year of typical use, but these methods are not reversible.  The 
most effective, reversible contraceptive methods are implants and intrauterine devices 
(IUDs; Figure 1, Tier 1) often collectively referred to as long-acting reversible 
contraception (LARC) because they are effective for a minimum of three years and fertility 
is rapidly restored upon removal.  Their <1% failure rate is due in part to the fact that after 
placement, they require virtually no effort on the woman’s part. Despite different types of 
LARCs being available for many years, use of these methods has historically been very 
low due to early design flaws, undesirable side effect profiles, and complications associated 
with placement and removal (Shoupe, 2016). Fortunately, newer models have improved 
Figure 1. Contraceptive Method Effectiveness. Reprinted from Efficacy, Safety, and   
 Personal Considerations. In: Hatcher R.A. Hatcher, eds. Contraceptive Technology.    







significantly in recent years. The levonorgestrel IUD was approved for use in 2000 and the 
single-rod implant was approved in 2006. In addition, availability of the copper IUD 
increased after 2005 due to labeling revisions that removed several major contraindications 
of use (Waknine, 2005). Other reversible contraceptive methods, including pills, patch, 
ring, and injectables (Figure 1, Tier 2), are less effective than LARCs or sterilization, but 
more effective than male condoms and withdrawal, two of the least effective methods for 
preventing pregnancy (Figure 1, Tier 3).  It is important to note that, when used correctly, 
male condoms can provide dual protection against both pregnancy and STIs. For example, 
male condoms reduce the risk of HIV transmission by approximately 90% (USAID, 2015). 
However, specific to pregnancy prevention, male condoms and other non-LARC methods 
(e.g. pills) are more prone to user error and imperfect adherence, both of which decrease 
their overall effectiveness, leading to estimated pregnancy rates of 13% for male condoms 
and 7% for pills in the first year of typical use (Trussell & Aiken, 2018).   
 Finally, although not typically described as a method of birth control, emergency 
contraception pills, sometimes referred to as Plan B or colloquially as the “morning after 
pill,” are a post-coital method used to avoid an unintended pregnancy.  The majority of 
emergency contraception pills currently available are effective if a woman uses them 
within 72 hours of unprotected intercourse; it does not have an effect on an established 
pregnancy (Haeger, Lamme, & Cleland, 2018; Trussell, Cleland, & Schwarz, 2018). 
Prevalence of family planning methods.  
 General population. Approximately 65% of all women of reproductive age in the 
general population report they or their partner are currently using contraception; this rises 







currently having intercourse, not pregnant or trying to conceive, and not sterile for non-
contraceptive reasons; Kavanaugh & Jerman, 2018). Most women are medically eligible 
for 10 or more contraceptive method options (Trussell, Aiken, Micks, & Guthrie, 2018) 
and therefore typically have many choices. The most common contraceptive methods 
women report currently using are pills (25%), female sterilization (22%), male condoms 
(15%), LARCs (14%), and male sterilization (7%; Kavanaugh & Jerman, 2018). Only 8% 
of women report use of multiple contraceptive methods, most often male condoms 
combined with another method (Guttmacher Institute, 2016). Approximately 20% of 
women report ever using emergency contraception (Centers for Disease Control and 
Prevention, 2019b).  
 Turning to men, the most common contraceptive methods men report they or their 
partner used at last intercourse are male condoms (35%), male sterilization (22%), and pills 
(21%; Stewart, Ritter, Bateson, McGeechan, & Weisberg, 2017). While most contraceptive 
methods are for use by women and there is a tendency to think of contraception solely as a 
woman’s responsibility (Brown, 2015; Fennell, 2011; Forste, 2003; Green & Biddlecom, 
2000; Hamm et al., 2019; Oudshoorn, 2004), research suggests that both men and women 
influence couple method choice and consistency of use (Grady, Klepinger, Billy, & 
Cubbins, 2010; Grady, Tanfer, Billy, & Lincoln-Hanson, 1996; Nguyen & Zaller, 2009; 
Wigginton, Harris, Loxton, & Lucke, 2018; Zolna, Lindberg, & Frost, 2011). Indeed, the 
majority of men report they want to participate in decisions related to contraception to 
address prevention of both pregnancy and STIs and believe men and women share this 
responsibility (Forste & Morgan, 1998; Grady et al., 1996; James-Hawkins, Dalessandro, 







Stewart et al., 2017). Furthermore, there is some research to suggest that contraceptive use 
may increase when male partners are involved in decision making about contraception 
(Widman, Welsh, McNulty, & Little, 2006).  
 Individuals receiving OAT.  Contraceptive use is not contraindicated for women 
receiving OAT (Curtis, Jatlaoui, et al., 2016), although a systematic review of  
contraceptive use among women with opioid and other substance use disorders suggests 
that only about half report current contraceptive use (Terplan, Hand, Hutchinson, 
Salisbury-Afshar, & Heil, 2015). The overall prevalence of current contraceptive use 
among women receiving OAT has been reported to range between 25-56% (Black et al., 
2012; Cornford, Close, Bray, Beere, & Mason, 2015; Harding & Ritchie, 2003; Krans et 
al., 2018; Morrison, Ruben, & Beeching, 1995; Poulton, Parlier, Scott, Fagan, & Shelley, 
2015; Ralph & Spigner, 1986). These rates are 2-2.5 times lower than rates reported by 
comparison groups of the general population (49-75%) (Cornford et al., 2015; Krans et al., 
2018; Ralph & Spigner, 1986). Furthermore, only approximately 50% of women receiving 
OAT who are at risk of unintended pregnancy (i.e. women currently having intercourse, 
not pregnant or trying to conceive, and not sterile for non-contraceptive reasons) report 
current contraceptive use, which is almost half the rate of contraceptive use reported by 
women at risk in the general population (90%; Black et al., 2012; Kavanaugh & Jerman, 
2018; Poulton et al., 2015). 
 The method women receiving OAT most commonly report using are male condoms 
(Black et al., 2012; Cornford et al., 2015; Fischbein et al., 2018; Harding & Ritchie, 2003; 
Morrison et al., 1995), although the high rate of unintended pregnancy among individuals 







Pierce, Tabrizi, Fairley, & Garland, 2005; Edelman, Patel, Glasper, & Bogen-Johnston, 
2014) as do high rates of STIs (Feaster et al., 2016; Lewis, Wu, & Ethelyn Strong, 2017; 
Novak, Ball, Winstock, & Peiper, 2016). There is very little information in the literature 
about the rates of current use of other contraceptive methods.  The best estimate to date 
may be a large study by Cornford et al. (2015) where methods included female sterilization 
(23%), combined pills/patch/ring (22%), injectables (19%), and LARCs (18%). Although 
the data regarding the types of contraceptive methods women receiving OAT report using 
is extremely limited, these percentages suggest that when women receiving OAT do use 
contraception, they are using it at rates similar to the general population. 
 In the one study we are aware of regarding contraceptive use reported by men 
receiving OAT, approximately a third of the men reported consistently using male condoms 
(Gilbert, El-Bassel, Wu, & Chang, 2007), similar to estimates of men in the general 
population (Reece et al., 2010). To our knowledge, there are no studies that assess female 
partner contraceptive use reported by men receiving OAT. Overall, these results suggest a 
large percentage of women and men receiving OAT do not use contraception at all, or use 
it inconsistently and/or ineffectively, thereby greatly increasing their risk of unintended 
pregnancy and STIs.  
 
Barriers to Contraceptive Use 
  There are multiple barriers that interfere with women obtaining and effectively 
using contraception including barriers to accessing services, poor fertility awareness, lack 
of knowledge about contraception (i.e. efficacy, mechanisms of action, safety), and 







Biggs, Karasek, & Foster, 2012; Frank, Poindexter, & Bateman, 1993; Frost & Darroch, 
2008; Frost, Lindberg, & Finer, 2012; Goodman, Onwumere, Milam, & Peipert, 2017; 
Johnston & Howie, 1985; Kakaiya, Lopez, & Nelson, 2017; Leeman, 2007; Marshall, 
Kandahari, & Raine-Bennett, 2018; Matteson & Hawkins, 1997; Maxwell, Devries, Zionts, 
Alhusen, & Campbell, 2015; Moreau, Cleland, & Trussell, 2007; Mosher et al., 2015; 
Nettleman et al., 2007; Pritt, Norris, & Berlan, 2017; Rosenberg, Waugh, & Meehan, 1995; 
Silverman, Torres, & Forrest, 1987; Stewart et al., 2017; Tanfer, 1994; Trussell, Stewart, 
Guest, & Hatcher, 1992; Widman et al., 2006; Zelnik & Kantner, 1979). Although more 
research is necessary to determine why individuals receiving OAT report low rates of 
contraceptive use overall, the data we do have suggests that barriers of contraceptive use 
reported by women receiving OAT are very similar to those reported by women in the 
general population (Bornstein, Gipson, Bleck, Sridhar, & Berger, 2019; Matusiewicz, 
Melbostad, & Heil, 2017; Meschke et al., 2018; Poulton et al., 2015; Smith et al., 2019).  
 Our group’s initial foray into research to reduce unintended pregnancy among 
women receiving OAT focused on reducing access barriers.  We devised a novel, intensive 
experimental family planning intervention informed by behavioral economic theory aimed 
at increasing both contraception initiation and continuation primarily by co-locating free 
family planning services with an OAT clinic. Results from both the initial Phase Ib trial 
(Heil et al., 2016) and an ongoing Phase II trial suggest eliminating access barriers greatly 
increases the use of contraception in this population. Nevertheless, results from the ongoing 
trial indicate that approximately 40% of women are not using contraception effectively at 
the end of the intensive intervention.  As a result, we have been considering various 







with more than 175 participants in our trials to date suggests that poor fertility awareness 
and deficits in contraceptive knowledge among both the female participants and their male 
partners may be a contributing factor to the lower rates of contraceptive use in this 
population.  Indeed, the scientific literature confirms that there is a dependable relationship 
between fertility awareness and contraceptive knowledge (hereafter referred to collectively 
as family planning knowledge) and contraceptive use.   
 General population. Poor family planning knowledge, including misperceptions 
and/or lack of awareness about the efficacy, mechanisms of action, safety, and potential 
side effects associated with contemporary contraceptive methods, is reliably associated 
with incorrect or inconsistent use and method discontinuation among women and men 
(Ayoola et al., 2007; Biggs & Foster, 2013; Callegari, Aiken, Dehlendorf, Cason, & 
Borrero, 2017; Carter, Bergdall, Henry-Moss, Hatfield-Timajchy, & Hock-Long, 2012; 
Dempsey, Billingsley, Savage, & Korte, 2012; Eisenberg et al., 2012; Foster et al., 2004; 
Foster, Ralph, Arons, Brindis, & Harper, 2007; Gilliam, Warden, Goldstein, & Tapia, 
2004; Grimes & Schulz, 2010; Hauck & Costescu, 2015; Hladky, Allsworth, Madden, 
Secura, & Peipert, 2011; Jaccard, Helbig, Wan, Gutman, & Kritz-Silverstein, 1996; 
Johnston & Howie, 1985; Jones, Darroch, & Henshaw, 2002; Kakaiya et al., 2017; Kollar, 
Biro, Boehner, & Rosenthal, 2000; Levinson, 1995; Lundsberg et al., 2014; Mackin, Clark, 
McCarthy, & Farris, 2015; Merchant et al., 2007; Mosher et al., 2015; Rosenberg et al., 
1995; Schrager et al., 2015; Tanfer, 1994). For example, in a study of contraceptive 
knowledge among a nationally representative sample of young adults, each additional 
correct response on a contraceptive knowledge scale was associated with a 17% increase 







likelihood of them having a partner who was using a prescription method was associated 
with an 11% increase (Frost et al., 2012). In addition, women in this study who 
underestimated the effectiveness of oral contraception (i.e. birth control pills) were more 
than twice as likely to report expecting to have unprotected intercourse in the next three 
months compared to women who accurately estimated the effectiveness of oral 
contraception. As another example, among a large convenience sample of women seeking 
primary care services, women who had never used an IUD were five times more likely to 
possess inaccurate knowledge about IUD effectiveness compared to current IUD users 
(Callegari, Parisi, & Schwarz, 2013).  
 Individuals receiving OAT. Information about family planning knowledge among 
women receiving OAT is very limited and to our knowledge there are no data available 
with respect to men.  In one qualitative study that investigated knowledge, attitudes, and 
beliefs about family planning among women enrolled in three substance abuse treatment 
programs in Baltimore, MD, at least one of which provided OAT, women demonstrated 
some knowledge about various methods, but also numerous misconceptions and 
inaccuracies (Robinowitz, Muqueeth, Scheibler, Salisbury-Afshar, & Terplan, 2016). For 
example, one woman accurately recalled information about different types of LARCs and 
described several benefits of using these methods, but other women reported inaccurate 
information about the efficacy of birth control pills and injectables and expressed 
uncertainty about using these methods. These results suggest that misinformation may be 
contributing to low rates of contraceptive use among women in treatment for OUD.  
Two quantitative studies, one of which we published, both utilized items from an 







Survey of Reproductive and 
Contraceptive Knowledge; 
Kaye, Suellentrop, & Sloup, 
2009) to assess knowledge 
about contraception among 
reproductive age women 
receiving OAT. Participants 
in our study (Matusiewicz et 
al., 2017) were women, 18-
49 years old, who were 
patients at the Chittenden 
Clinic, a large, outpatient 
OAT facility in Burlington, 
VT and who completed an 
eligibility screening for our ongoing randomized clinical trial described earlier. Overall, 
women receiving OAT knew as much about IUDs as short-acting methods and male 
condoms, but knowledge about implants was consistently lower than all other methods 
assessed (Figure 2).  Knowledge about male condoms, pills, injectables, and IUDs 
appeared very similar to that reported by women in the National Campaign sample (Kaye, 
Suellentrop, & Sloup, 2009), although the National Campaign sample was limited to 
unmarried women between the ages of 18 and 29.  
Utilizing some of the same survey items, Meschke et al. (2018) recently published 












Figure 2.  Correct Responses to Contraceptive 
Knowledge Questions as a Function of Method Type. 
Reprinted from “Knowledge of and concerns about long-
acting reversible contraception among women in 
medication-assisted treatment for opioid use disorder,” 







services from two different clinics in eastern Tennessee were invited to participate. 
Responses to items assessing knowledge about specific contraceptive methods were 
aggregated to form an overall knowledge score, although they did include a subset of 
questions specifically about IUDs. Women in this study answered approximately 60% of 
the questions about overall knowledge correctly and 42% of the IUD questions correctly. 
While these studies provide important preliminary information about levels of 
contraceptive knowledge among women receiving OAT, there are several limitations that 
should be noted. First, differences in methodology between the two quantitative studies 
prevent a direct comparison of results. For example, Matusiewicz et al. (2017) published 
data about knowledge of individual methods compared to the emphasis on overall 
knowledge by Meschke et al. (2018). Second, women in both studies were only asked about 
some methods (e.g. there are no questions about emergency contraception) and there were 
no questions about fertility awareness. Third, no data were collected from men in either 
study. Finally, neither study included a comparison group, which compromises the ability 
to place results in a larger context.   
 
Assessment of Family Planning Knowledge 
 While many studies have found a positive association between family planning 
knowledge and contraceptive use, it is interesting to note that there is no commonly-used 
tool to assess fertility awareness or to measure contraceptive knowledge. For example, 
results from a systematic review of 21 studies that assessed measurement of knowledge 







in part due to an almost complete lack of validity and reliability testing (Hall, Castaño, 
Stone, & Westhoff, 2010).  
Recently, Haynes and colleagues published the Contraceptive Knowledge 
Assessment (CKA; Appendix; Haynes, Ryan, Saleh, Winkel, & Ades, 2017).  Although 
the title of the CKA specifies “contraceptive knowledge,” this 25-item, multiple-choice 
measure assesses family planning knowledge more broadly, including fertility awareness, 
contraceptive method knowledge (including all contemporary methods), and pregnancy 
prevention self-efficacy. Validity of this novel assessment tool was established primarily 
by expert review (Haynes et al., 2017). Among study participants, test-retest analysis 
revealed no significant difference in total mean score and the high correlation between 
initial and follow-up administration of the CKA (R=0.79, p=.667) demonstrates good 
reliability for the assessment of family planning knowledge (Haynes et al., 2017). 
In addition to providing a total CKA score, our examination of CKA questions 
suggests that many could be grouped together to provide information about knowledge in 
particular content areas that may help identify specific deficits in knowledge. Independent 
expert review by two board certified obstetrician/gynecologists identified five categories: 
1) fertility awareness, 2) general contraceptive knowledge, 3) short-acting contraception 
knowledge, 4) long-acting reversible contraception knowledge, and 5) other contraceptive 










The “fertility awareness" category consists of three questions related to factors that 
affect conception, such as when during a woman’s cycle is she most likely to get pregnant. 
The “general contraceptive knowledge” category consists of six questions broadly related 
to contraceptive method attributes such as which method of birth control is most effective. 
The “short-acting reversible contraception knowledge” category consists of nine questions 
about pills, patch, ring, and injections. The “long-acting reversible contraception 
knowledge” category consists of three questions about IUDs and implants. The “other 
contraceptive methods knowledge” category consists of four questions about male 
condoms, withdrawal, or emergency contraception.  
  
Table 1.  Distribution of Contraceptive Knowledge Assessment (CKA) 
Questions into Content Areas 
Content Area CKA Questions in the Content Area  
Fertility Awareness 1, 2, 3 
General Contraceptive Knowledge 5, 6, 15, 18, 19, 21 
Short-acting Contraception Knowledge 8, 9, 10, 11, 12, 13, 14, 16, 17 
Long-acting Reversible Contraception Knowledge 20, 22, 23 







Role of Family Planning Knowledge in Interventions 
  As described previously, there is a reliable association between family planning 
knowledge and contraceptive use evident in at least two dozen studies.  It has often been 
assumed that this association is causal and as a result, one of the most common approaches 
of efforts to change this and many other health behaviors has been education or 
information-based approaches in which knowledge is provided to prompt individuals to 
change their behavior (Bandura, 2004; Bettinghaus, 1986; Glanz, Rimer, & Viswanath, 
2008; Marteau, Hollands, & Kelly, 2015; Michie, West, Campbell, Brown, & Gainforth, 
2014; Rosenstock, Strecher, & Becker, 1988; Ryan, 2009).  However, these interventions 
have often not been effective. Specific to family planning, a recent systematic review of 
the effect of contraceptive education on knowledge, contraceptive use, and incidence of 
pregnancy underscores this disconnect. Pazol et al. (2018) identified 31 studies that tested 
36 interventions that provided contraceptive education.  Ninety percent of these studies 
(28/31) reported a significant increase in knowledge after receipt of education about 
contraception. However, among the nine studies that also examined the effect of 
contraceptive education on a variety of measures of contraceptive use (e.g., contraceptive 
initiation; correct, consistent, or continued use of contraception), only five reported 
significant improvements in contraceptive use.  The one study that examined incidence of 
pregnancy reported a positive effect of the intervention on decreasing rates of pregnancy 
at the time of follow-up, although this result was only marginally significant.  
 While it now appears overly simplistic to believe that increasing knowledge alone 
will lead directly and reliably to healthier behavior, there is little question that knowledge 







recently stated, “What people know and what they do with what they know has a major 
impact on their life chances.” (Centers for Disease Control and Prevention, 2016). As a 
result, many major theories of and approaches to changing health behavior include 
knowledge, implicitly or explicitly, in one or more components of these models.   
 Behavioral economics. As noted previously, we are interested in the application 
of behavioral economics theory to contraceptive use among women receiving OAT who 
are at risk of unintended pregnancy.  The field of behavioral economics, which began in 
the 1990s, integrates psychological science with economic principles and has identified a 
number of cognitive biases that often lead people to make health and other decisions that 
are not consistent with their stated health goals.  Ashton et al. (2015) recently published a 
framework for applying behavioral economics to reproductive health outcomes.  The 
framework groups many of the cognitive biases identified by behavioral economics under 
four sets of competing forces that each exist on a continuum (Table 2).   
 While knowledge about family planning per se is not an explicit part of the 
framework, it is easy to see how knowledge plays a role in a number of biases in the 
framework.  For example, Illusion  Reality: Beliefs about probability may apply to 
Table 2. Behavioral Factors That Influence Decision Making About 
Reproductive Health 
Illusion  Reality 
Thinking Fast  
Thinking Slow 
Today  Tomorrow Self  Other 
• Beliefs about facts • Mental shortcuts • Present bias • Persuasion 
• Beliefs about probability • Limited attention • Emotions, visceral drives • Social norms, pressure 
• Beliefs about preferences • Intuition • Sensation seeking • Perceptions of social norms 
   • Altruism, reciprocal fairness 
   • Identity 
Note. Adapted from “A review of behavioral economics in reproductive health,” by L. Ashton et al., 
2015, UC Berkeley: Center for Effective Global Action White Papers, 44, pp.16-25.  
 







assessments about fertility and pregnancy risk. As previously discussed, many women, 
including women receiving OAT, assess their risk of pregnancy based on menstrual cycle 
functioning (i.e. fertility awareness) and inaccurately assume menstrual cycle irregularities 
reduce their fertility and subsequent risk of pregnancy. These inaccurate beliefs about the 
low perceived probability of getting pregnant may increase pregnancy risk and contribute 
to low rates of contraceptive use. Consequently, increasing fertility awareness may 
contribute to decreasing the risk of unintended pregnancy by helping women and couples 
more accurately assess the probability of getting pregnant and may promote increased use 
of contraception during the “fertile window.” 
 The Thinking Fast  Thinking Slow: Mental shortcuts continuum also implicitly 
addresses how people use knowledge and information to make decisions. Mental shortcuts 
refer to rules of thumb that individuals utilize to make decisions (Tversky & Kahneman, 
1974). These shortcuts, sometimes referred to as heuristics, are useful because they make 
the complex task of assessing decisions in terms of probability, benefits/risk, and outcomes 
manageable by creating a mental shortcut. However, heuristics based on inaccurate 
information could lead to less optimal decisions.  For example, as noted previously, the 
majority of emergency contraception pills currently available are effective if women use 
them within 72 hours of unprotected intercourse.  However, if an individual has developed 
a heuristic for emergency contraception pills that includes the “morning after pill” 
colloquialism, she/he may limit use of this method to the first 24 hours after unprotected 
intercourse, even though it would still be effective for 72 hours.  There is research that 
suggests individuals in the general population are misinformed about emergency 







receiving OAT. In a study of young adults in the general population, 80% of participants 
were aware of the emergency contraception pill, but only 44% correctly reported that this 
method can be typically be used up to three days after unprotected intercourse (Yen, 
Parmar, Lin, & Ammerman, 2015), suggesting many are not maximizing the use of 
emergency contraception pills to decrease the risk of an unintended pregnancy. 
Consequently, increasing knowledge about family planning methods may decrease the risk 
of unintended pregnancy by modifying mental short cuts individuals rely on to inform their 
contraceptive behavior.  
Another example is found in the Today  Tomorrow: Present bias continuum.  
Present bias is the tendency to over-value immediate rewards at the expense of long-term 
intentions.  Applied to contraceptive behavior, individuals may be more likely to choose 
not to use contraception, which does not have any upfront costs in terms of money, time,  
 
or effort (Table 3, top row), instead of going through the costly process of obtaining 
contraception, with the more effective methods requiring additional upfront costs  (Table 
3, bottom row).  While everyone has this bias to some degree or another, calculation of the 
Table 3. Present Bias as it Applies to Different Types of Contraception  
 Initiation Costs/Efforts Continuation Costs/Efforts Gains 
No 
Contraception 
• No planning ahead 
• No cost 
• No planning ahead 
• No cost 
• 85% chance of 
pregnancy 
Condoms 
• Available over the counter 
at various locations 
• Relatively inexpensive 
• Remember to use method 




• Visit with a qualified 
healthcare provider 
• Relatively expensive 
prescription (pills, patch, 
ring) and somewhat 
uncomfortable procedure 
(injection, IUD, implant) 
• Tolerate bothersome, but 
rarely, medically serious, 
side effects 
• Remember to use method 
(pills, patch,  ring, injection) 









literal and figurative costs will be influenced by an individual’s knowledge.  For example, 
as Table 3 indicates, continuation costs for the more effective methods (i.e. prescription 
contraceptives) include tolerating bothersome but rarely medically serious side effects.  If 
an individual mistakenly believes that IUDs can cause infections that lead to infertility, 
she/he is likely to inaccurately assess the figurative costs of that method, thereby 
decreasing the likelihood of choosing this highly effective methods.  We recently asked 
women receiving OAT who reported they were unlikely to use an IUD why they were 
unlikely to choose this method; nearly half (45%) reported it was because they were 
concerned about getting an infection (Matusiewicz et al., 2017).  This misperception may 
be adversely impacting calculation of the costs of IUDs despite their near-perfect rate of 
effectively preventing pregnancy. Therefore, increasing knowledge about contraception 
may contribute to decreasing the risk of unintended pregnancy by modifying the value 
individuals place on the immediate versus long-term costs and benefits of using 
contraception. 
 Other theoretical models. While we approach the issue of contraceptive decision-
making among women and men receiving OAT from a behavioral economics perspective, 
there are of course other theoretical models that address health behaviors like contraceptive 
decision-making. A recent review by Lopez et al. (2016) reported on 25 theory-based 
interventions for contraception. The authors grouped interventions by theory and found 
that the majority of the studies reviewed were based on one of two theories or approaches. 
Most common was a social cognitive approach like the Health Belief Model (HBM). Social 
cognitive approaches suggest that decisions about health behavior are made deliberately 








in behavior are achieved 
by targeting 




behavior (Glanz et al., 
2008; Rosenstock et al., 
1988; Sallis & Owen, 





Interviewing (MI) with 
those that were rooted in 
the Information-Motivation-Behavior Skills (IMB) Model. MI also presumes changes in 
health behavior are defined by an assessment of the costs and benefits associated with 
engaging in a particular behavior (Prochaska & DiClemente, 1982, 1986). As a clinical 
technique, the goal of MI is for providers to engage their patients, elicit change talk, and 
evoke patient motivation to support positive behavioral changes.  The IMB Model suggests 
that information and motivation influence health behavior change by activating skills 
Perceived Benefits: 
- Knowledge of    
  efficacy 
- Beliefs about  
  efficacy 
- Method feasibility 
- Initiation method 
 
Perceived Barriers: 
- Perceived side  
  effects 





    Likelihood of a Contraceptive Behavior 





- Pregnancy  
  knowledge 
- Pregnancy beliefs   
Internal: 
- Missed menses 
 
External: 
- Provider    





Demographics: Age, race, education 
Reproductive: Prior contraceptive use, prior unwanted pregnancy 
Psychological: Forgetfulness, emotional wellbeing   
Social: Partner status, domestic abuse 
Structural: Health insurance, lack of daily routine  
  
Modifying and Enabling Factors and Examples of Each 
Contraceptive Decision Making 
Figure 3. Contraceptive Behavior Health Belief Model. 
Adapted from “The Health Belief Model can guide modern 
contraceptive behavior research and practice,” by K. Hall, 







necessary to reduce risky behaviors and maintain behavioral change (Fisher & Fisher, 
1992).  
While all three of these approaches have somewhat different perspectives, 
knowledge is included in components of all three frameworks.  In a revised version of the 
HBM that focused on contraception (Hall, 2012), pregnancy knowledge and knowledge of 
the efficacy of 
contraceptives are 
included in two different 
components (Figure 3, 
upper left and right 





use neutral and non-
judgmental questions (e.g., “Are you interested in learning more about …?” or “What do 
you know about the benefits of …?”) to introduce factual information into sessions or 
correct misinformation in an effort to help patients identify advantages and disadvantages 
of initiating a specific health behavior (Rollnick, Butler, Kinnersley, Gregory, & Mash, 
2010; Sobell & Sobell, 2013). Finally, as the title and description of the IMB model 
indicates, information (or knowledge) about risk reduction is an explicit component of this 
model (Figure 4; Boyer et al., 2005; Fisher & Fisher, 1992).  
Figure 4. Information-Motivation-Behavioral Skills     
 Model. Adapted from “Changing AIDS-risk behavior,”  

















Consistently low rates of contraceptive use and high rates of unintended pregnancy 
suggests an unmet need for effective contraceptive use among women and men receiving 
OAT. As described earlier, there is a reliable, but rarely causal, relationship between family 
planning knowledge and contraceptive behavior. The complexity of the theoretical models 
reviewed suggests that knowledge plays a role in behavior, although on its own, knowledge 
will seldom be sufficient to elicit substantial behavior change. There are limited data about 
family planning knowledge among women and men receiving OAT, which has 
implications for how best to proceed with efforts to increase contraceptive use and reduce 
unintended pregnancy in this population. If there is a deficit in family planning knowledge, 
the literature reviewed earlier suggests that increasing knowledge alone is unlikely to cause 
substantive behavior change.  However, as one example, the HBM suggests that accurate 
knowledge of pregnancy risk and contraceptive efficacy, when combined with other 
components of the model like effective provider counseling, could lead to significant 
changes in behavior.  As another example, an MI approach suggests that clinical feedback 
that includes accurate information about contraceptive method side effects, when combined 
with MI techniques like open-ended questions that assess patient responses to the 
information and efforts to elicit change talk, could lead to significant changes in behavior.  
If there is not a substantive deficit in family planning knowledge, then interventions should 
focus on additional factors that influence behavior.  For example, behavioral economics 
might suggest an intervention that reduces literal and figurative costs of accessing 







patient-provider relationship and explore how the health care provider might influence 
contraceptive decision-making (e.g. cues to actions).   Thus, characterizing family planning 
knowledge among women and men receiving OAT will help provide direction to efforts to 
increase contraceptive use and decrease unintended pregnancy in this high-risk population.   
The aims of this study were:  
 Aim 1 (Primary). Examine family planning knowledge among women and men 
receiving OAT as compared to women and men receiving PC services. The latter sample 
was selected as the comparison group because these individuals are also receiving an 
outpatient medical service and can serve as a proxy for the general population.  
 Hypothesis 1a. Consistent with observations of low rates of contraceptive use and 
high rates of unintended pregnancy among individuals receiving OAT, the mean percent 
of correct responses on the CKA will be lower (i.e. less knowledge about family planning) 
among the OAT sample compared to the PC sample.  
 Hypothesis 1b. Consistent with the tendency for society to see pregnancy 
prevention and contraceptive use as primarily women’s issues, women in both samples (i.e. 
receiving OAT or PC) will have a higher mean percent of correct responses on the CKA 
(i.e. more family planning knowledge) than men. 
  Aim 2 (Exploratory). Evaluate specific content areas of family planning 
knowledge among women and men receiving OAT compared to women and men receiving 
PC.  We will compare the mean percent of correct responses on the CKA in the areas of 1) 
fertility awareness, 2) general contraceptive knowledge, and knowledge of 3) short-acting 







between patient samples and between sexes but are not proposing specific hypotheses for 
these outcomes.    
            Aim 3 (Exploratory). Examine the potential interaction of patient sample and sex 
on family planning knowledge.  If main effects of patient sample and sex are significant 
for the mean percent of correct responses on the CKA and/or among the five content areas 
(i.e. fertility awareness, general contraceptive knowledge and knowledge of short-acting, 
long-acting, and other contraceptive methods) we will look at their interaction, but are not 










Patient Samples and Settings 
Patients receiving OAT.  A cross-sectional survey of women and men receiving 
OAT was conducted. Research staff recruited patients receiving either methadone or 
buprenorphine from the Chittenden Clinic, a large (~1,000 patients), outpatient treatment 
facility in Burlington, VT. Due to federal regulations, this OAT facility cannot treat 
individuals less than 18 years old, so all patients were at least 18 years old. All women and 
men receiving OAT were eligible to participate in this study, although final analysis was 
restricted to women and men of reproductive age (18-45 years old) because family planning 
is most relevant to this age group.  
Family planning services are very limited in this setting.  According to Chittenden 
Clinic protocol, both women and men are asked about current contraceptive use at intake 
and women are administered pregnancy tests once a month during treatment. A positive 
urine pregnancy test results in a referral to a University of Vermont Medical Center 
(UVMMC) obstetrics practice that manages pregnant women receiving OAT. Women may 
also receive additional reproductive health referrals (e.g. gynecological care). Male 
condoms are available free of charge to all patients onsite at the Chittenden Clinic.  No 
other family planning services are provided.  
Patients receiving PC.  For comparison, a cross-sectional survey of women and 
men receiving PC from two UVMMC-affiliated practices in Burlington, VT was 
conducted. Research staff recruited patients from UVMMC Adult Primary Care and 







eligible to participate. To be consistent with the OAT sample, patients less than 18 years 
old were not eligible to participate. Patients in these practices receive a wide range of health 
care services related to health promotion, disease prevention, diagnosis and treatment of 
acute and chronic illnesses, and education and counseling about various health issues. 
Family planning services can be integrated into primary care, although the breadth and 
depth of such services vary by provider. Women and men are typically asked about their 
current contraceptive use at annual exams and may be provided sexual and reproductive 
health counseling where indicated. A positive pregnancy test results in a referral to a local 
obstetrics practice.  
All practice administrators (i.e. Chittenden Clinic, UVMMC Primary Care and 
Appletree Bay Primary Care) approved all study procedures. The Institutional Review 
Board of the University of Vermont also approved this study. 
 
Measures  
Family planning knowledge was measured with the previously-described 
Contraceptive Knowledge Assessment (CKA; Appendix). All 25 questions are multiple 
choice, with five answer choices, except for one question (Question 21) that has six 
possible responses.  “I don’t know” is the final possible answer for all 25 questions. 
Consistent with the recommendations of others (Trussell, 2017), we modified the wording 
of one of the responses for three different CKA questions to be more accurate. First, on 
Question 4, we changed “semen” to “sperm” because pre-ejaculate does not contain semen 
(Killick, Leary, Trussell, & Guthrie, 2011). Second, on Question 10, we changed the 







continuously for one month, with no hormone-free days (Zieman, Hatcher, Allen, Lathrop, 
& Haddad, 2016).  Third, on Question 24, we replaced the response “five days” with “three 
days” to reflect U.S. Food & Drug Administration packaging on levonorgestrel emergency 
contraception (U.S. Food & Drug Administration, 2016). We also changed “doctor” to 
“provider” on Questions 20 and 23 to be more inclusive of all health care providers.  
 
Procedures  
Study recruitment occurred in designated areas of the OAT and PC office waiting 
rooms at various times throughout a given week (3-4 hours a day, 2-3 times per week). 
Interested patients had the opportunity to discuss study participation with research staff 
either before or after their appointments.  Participants were asked to provide very basic 
demographic information and then completed a paper copy of the CKA. The average time 
to complete the questionnaire was approximately 10 minutes; total study participation time 
was less than 15 minutes. Upon completion of the CKA, participants were offered a copy 
of the correct answers to take home. Participants were compensated with a $20 gift card 
for their time.  
 
Analysis 
 The percentage of correct responses for all CKA questions for each participant was 
calculated. Primary and exploratory hypotheses were tested using two-way analysis of 
variance (ANOVA) with fixed factors, patient sample (i.e. receiving OAT or PC) and sex 
(i.e. female or male) along with their interaction. Analyses of the five content areas (i.e. 







long-acting, or other contraceptive methods) paralleled those conducted to calculate the 
percentage of correct responses for all CKA questions. The normality and homogeneity of 
variance assumptions associated with two-way ANOVAs were examined based on normal 
probability plots of residuals and Levene’s test, respectively. Participant age was examined 
as a potential covariate because there was a significant difference in age between the OAT 
and PC patients samples and between women and men. Unadjusted values for mean percent 
correct are presented for the total CKA score and the five content areas because controlling 
for age did not have a significant effect on results.  
  A sample size of 320 participants (n=80/group) was estimated to have power (1-
) = .80 using α=.05 to detect an effect size (Cohen’s d) = 0.28 for main effects of patient 
sample and sex on our primary outcome of total correct responses on the CKA. This effect 
size represents a small to medium effect size. This power and estimated effect size also 
applies to analyses of the five content areas of family planning knowledge. 
 Analyses were conducted using StataSE version 15 (Stata Statistical Software: 
Release 15. College Station, TX: StataCorp LLC) and SAS statistical software version 9.4 











 Overall, 332 participants completed this survey. There was a total of 167 patients 
receiving OAT (women: n=85, men: n=82) and 165 patients receiving PC (women: n=84, 
men: n=81; Table 4). Overall, the mean age of participants was 32.1 years. On average,  
patients receiving OAT were significantly older compared to PC patients, 32.9  vs. 31.3 
years, respectively, F(1,328) = 6.02 p<.05. On average, females were significantly younger  
compared to males, 31.2 vs. 33.0 years, respectively, F(1,328) = 6.87 p<.01. There was no 
significant interaction effect between patient sample and sex for age, F(1,328) = 0.02, 
p< .89. The overwhelming majority of participants were white (86%) and there were no 
differences by patient sample or sex. 
 
CKA Responses 
 CKA total. Overall, the mean percent of correct responses on the 25 CKA 
questions was 50% (mean=12.5), with a range of 4% to 88%. On average, patients 
receiving OAT answered 47% (mean=11.8) of the 25 CKA questions correctly compared 
to 53% (mean=13.3) for patients receiving PC (Figure 5, top left panel). Simple main 
effects analysis of patient sample showed patients receiving OAT had a significantly lower 
mean percentage of correct responses compared to patients receiving PC, F(1,328) = 11.6 
p<.001. On average, women answered 56% (mean=13.9) of the 25 CKA questions 
correctly compared to 44% (mean=11.1) for men (Figure 5, top right panel). Simple main 







correct responses than men, F(1,328) = 38.47, p< .0001. The interaction effect between 
patient sample and sex was not significant, F(1,328) = 0.12, p=.73 (Figure 5, bottom panel). 
 CKA content areas.  
  Fertility awareness. Overall, the mean percent of correct responses on the three  
fertility awareness questions was 53% (mean=1.6; Table 5). On average, patients  
receiving OAT answered 49% (mean=1.5) of the three questions correctly compared to 
58% (mean=1.7) for patients receiving PC.  Simple main effects analysis of patient 
sample showed that patients receiving OAT knew significantly less about fertility 
awareness compared to patients receiving PC, F(1,327) = 10.33, p<.01. On average, 
women answered 58% (mean=1.7) of the three questions correctly compared to 48% 
(mean=1.5) for men. Simple main effects analysis of sex showed that women knew 
significantly more about fertility awareness than men, F(1,327) = 10.90, p<.01. The 
interaction effect between patient sample and sex was not significant, F(1,327) = 0.00, 
p=.97. 
General contraceptive knowledge. Overall, the mean percent of correct responses 
on the six questions about general contraceptive knowledge was 66% (mean=4.0; Table 5). 
On average, patients receiving OAT answered 62% (mean=3.7) of the six questions 
correctly compared to 70% (mean=4.2) for patients receiving PC. Simple main effects 
analysis of patient sample showed that patients receiving OAT knew significantly less 
about general family planning compared to patients receiving PC, F(1,327) = 11.47, 
p<.001. On average, women answered 70% (mean=4.2) of the six general contraceptive  
knowledge questions correctly compared to 62% (mean=3.7) for men. Simple main effects 







compared to men, F(1,327) = 7.92, p<.01. The interaction effect between patient sample 
and sex was not significant, F(1,327) = 1.42, p=.23. 
Short-acting contraception knowledge. Overall, the mean percent of correct 
responses on the nine questions about short-acting contraception (i.e. pills, patch, ring, and 
injectables) knowledge was 37% (mean=3.4; Table 5). On average, patients receiving OAT 
answered 37% (mean=3.3) of these nine questions correctly, similar to 38% (mean=3.4) 
for patients receiving PC. There was no significant difference in knowledge about short-
acting contraception between the patient samples, F(1,327) = 0.14, p=.66. On average, 
women answered 45% (mean=4.0) of the nine questions about short-acting contraception 
correctly compared to 30% (mean=2.7) for men. Simple main effects analysis of sex 
showed that women knew significantly more about short-acting contraception compared 
to men, F(1,327) = 45.00, p<.001. The interaction effect between patient sample and sex 
was not significant, F(1,327) = 0.50, p=.48. 
Long-acting reversible contraception knowledge. Overall, the mean percent of 
correct responses on the three questions about long-acting reversible contraception (i.e. 
implants and IUDs) knowledge was 43% (mean=1.3; Table 5). On average, patients 
receiving OAT answered 38% (mean=1.1) of the three questions correctly compared to 
48% (mean=1.4) for patients receiving PC. Simple main effects analysis of patient sample 
showed that patients receiving OAT knew significantly less about long-acting 
contraception compared to patients receiving PC, F(1,327) = 9.20, p<.01. On average, 
women answered 53% (mean=1.6) of the three questions correctly compared to 33% 
(mean=1.0) for men. Simple main effects analysis of sex showed that women knew 







= 39.71, p<.001. The interaction effect between patient sample and sex was not significant, 
F(1,327) = 0.51, p=.47. 
Other contraceptive methods knowledge. Overall, the mean percent of correct 
responses on the four questions about other contraceptive methods (i.e. withdrawal, 
condoms, and emergency contraception) knowledge was 58% (mean=2.3; Table 5). On 
average, patients receiving OAT answered 53% (mean=2.1) of these four questions 
correctly compared to 62% (mean=2.5) for patients receiving PC. Simple main effects 
analysis of patient sample showed that patients receiving OAT had significantly less 
knowledge about other methods compared to patients receiving PC, F(1,327) = 9.99, p<.01. 
On average, women answered 59% (mean=2.4) of the four questions about other 
contraceptive methods correctly compared to 56% (mean=2.2) for men. There was no 
significant difference in knowledge of other methods between women and men, F(1,327) 
= 1.17, p=.28. The interaction effect between patient sample and sex was also not 










To continue efforts to understand why rates of unintended pregnancy are 
approximately two-fold higher among women receiving OAT than women in the general 
population, this study compared knowledge about family planning among women and men 
receiving OAT to a sample of women and men receiving PC. Overall, our findings indicate 
that there are significant effects of both patient sample (i.e. OAT vs. PC) and sex (i.e. 
females vs. males) on the total score on the CKA as well as most of the content areas. 
Differences in family planning knowledge (or lack thereof) as a function of patient sample 
will be discussed first, followed by those as a function of sex.   
Patient Sample 
Total score. The mean percent of correct responses on the CKA among individuals 
receiving OAT was approximately 10% lower than individuals receiving PC. However, 
patients in both samples answered only approximately 50% of the CKA questions 
correctly, indicating significant gaps in family planning knowledge for all participants. 
While the difference between patient samples was statistically significant, it is less clear 
how clinically important a difference of around 5%, or 1.5 questions, is.  Given that the 
rate of unintended pregnancy among women receiving OAT is almost double that of the 
general population (Black et al., 2012; Finer & Zolna, 2016; Fischbein et al., 2018; 
Kreitinger et al., 2016; Meschke et al., 2018; Smith et al., 2019; Welle-Strand et al., 2015), 
it is somewhat surprising that individuals receiving OAT did not have substantially lower 
levels of family planning knowledge.  The theoretical approaches described in the 







decisions about contraceptive behavior are the compound result of a multitude of factors. 
The present results suggest that deficits in knowledge, by themselves, are likely only 
playing a small role in the large discrepancy in rates of contraceptive use and unintended 
pregnancy among women receiving OAT and women in the general population, although 
improving knowledge in combination with other approaches may have a larger effect.   
 Interestingly, the mean percent of correct responses on the CKA for both patient 
samples was at least 25% higher than the patient sample reported by Haynes et al. (2017) 
in the original report on the CKA.  These differences may be a function of characteristics 
of their patient sample, which they described as an ethnically diverse group of medically 
underserved and underinsured patients, 15 to 45 years old, attending an urban ambulatory 
care center. Research consistently demonstrates ethnic and racial disparities in 
contraceptive knowledge, effective use of contraception, and pregnancy intention in the 
general population (Borrero, Farkas, Dehlendorf, & Rocca, 2013; Craig, Dehlendorf, 
Borrero, Harper, & Rocca, 2014; Finer & Zolna, 2016; Grady, Dehlendorf, Cohen, Bimla 
Schwarz, & Borrero, 2015; Rosenfeld et al., 2017; Stidham Hall et al., 2016). These 
disparities appear to be driven by psychosocial and economic differences, such as age, US 
nativity, education, and income (Dehlendorf et al., 2014; C. D. Grady et al., 2015; Jackson, 
Wang, & Morse, 2017; Kim, Dagher, & Chen, 2016). While neither the Haynes et al. study 
nor the present study collected more than basic demographic information from participants, 
a possible difference in age and likely differences in US nativity between these samples 
may have contributed to the higher mean percent of correct responses in the present study 







 With regard to age, the Haynes et al. study team purposefully included adolescents 
ages 15 to 17  in their eligible age range because this age group has a high risk of unintended 
pregnancy (72%; Finer & Zolna, 2016). While we agree with this rationale, federal 
regulations require that patients who receive OAT from adult, outpatient treatment 
facilities must be at least 18 years old; thus, the Chittenden Clinic population does not 
represent the full reproductive age range.  Adolescents may have less knowledge about 
family planning because they have had less time to be exposed to this information in school, 
at home, and in other settings.  It is unclear what percentage of the Haynes et al. sample is 
adolescents; if the proportion was substantial, this may have contributed to the overall 
lower scores of that sample.   
 With regard to US nativity, conversations with the Haynes et al. study team 
revealed that they recruited all of their participants from Bellevue Hospital in New York 
City, NY, whose patient population is estimated to have a high rate of foreign-born patients 
(personal communication, 7/13/2018). By contrast, the overwhelming majority of Vermont 
residents are non-Hispanic and only 5% of the population is foreign-born (US Census 
Bureau, 2018), making it very likely that there were few patients in either the OAT or PC 
samples in the present study that were not born in the US.  Foreign-born women living in 
the US are less likely to have access to healthcare compared to US-born women which has 
been shown to contribute to lower rates of family planning service utilization, thereby 
decreasing opportunities to receive education and counseling about contraception (Tapales, 
Douglas-Hall, & Whitehead, 2018). This may in turn have contributed to lower levels of 
knowledge in the Haynes et al. sample. 







Fertility awareness. Examination of CKA questions by specific content provides 
useful information about the similarities and differences in five areas of family planning 
knowledge between these two patient samples. The  percent of correct responses about 
fertility awareness was approximately 16% lower among individuals receiving OAT 
compared to the individuals receiving PC. As discussed in the Introduction, cognitive 
biases such as inaccurate beliefs about the perceived probability of a health risk can 
contribute to less optimal decision-making about health.  Consistent with this, studies have 
shown that poor fertility awareness contributes to an increased likelihood that 
women/couples will incorrectly assess their risk of pregnancy (Lundsberg et al., 2014) and 
a decreased likelihood of contraceptive use (Mosher et al., 2015; Nettleman et al., 2007). 
Poor fertility awareness may be exacerbated among individuals receiving OAT because 
women receiving OAT report high rates of menstrual irregularities (Dürsteler-MacFarland 
et al., 2010; Haber et al., 2017; Santen, Sofsky, Bilic, & Lippert, 1975; Schmittner, 
Schroeder, Epstein, & Preston, 2005). In the largest and most detailed study of menstrual 
cycle function among women receiving OAT, only 28% of more than 100 women had 
regular menstrual cycles, defined as 20-40 days in length (Schmittner et al., 2005). 
Menstrual irregularities make it more difficult to predict fertility status (i.e. when a woman 
is most likely to become pregnant) and may contribute to misperceptions about the 
probability of becoming pregnant. Inaccurate assessments about pregnancy risk may in turn 
interfere with effective use of contraception, thereby increasing the risk of unintended 
pregnancy.  
Given the increased frequency of cycle-length irregularities among women 







window.  Incorporating information about fertility awareness into family planning 
interventions for individuals receiving OAT, with an emphasis on the potential side effects 
of agonist medication and other substance use on menstruation, may contribute to 
decreasing the risk of unintended pregnancy by clarifying that menstrual irregularities are 
not synonymous with infertility, thereby helping women/couples to more accurately assess 
pregnancy risk.  
General contraceptive knowledge. There was a significant difference in general 
knowledge about contraception between patient samples: patients receiving OAT scored 
approximately 10% lower than patients receiving PC.  However, patients in both samples 
answered two thirds of these questions correctly, suggesting that both groups are fairly 
well-informed with regard to general information regarding contraception. Given this, 
efforts to improve contraceptive knowledge may be more impactful if they target the larger 
knowledge deficits in fertility awareness and method-specific content areas (i.e. short- and 
long-acting contraception, and other contraceptive methods) rather than allocating 
resources to improve general knowledge about contraception.  
Short-acting contraception knowledge. Although there were no differences in 
knowledge about short-acting contraception between patient samples, the overall low level 
of knowledge about short-acting methods is clinically concerning and may help explain 
why there is a 7% discrepancy in the rate of pregnancy between perfect use and typical use 
of pills, the most commonly used short-acting contraceptive method among women in the 
general population (Kavanaugh & Jerman, 2018; Trussell et al., 2018). In addition, the user 
demands associated with short-acting methods (e.g. remembering to take a pill every day), 







Therefore, incorporating information about mechanisms of action and attributes of short-
acting methods into family planning interventions may increase knowledge about these 
methods and promote more effective use.  
Long-acting reversible contraception knowledge. Examination of the long-acting 
reversible contraception knowledge content area identified there was a significant 
difference in LARC knowledge between patient samples. Individuals receiving OAT 
scored approximately 20% lower than individuals receiving PC in this content area. This 
discrepancy is somewhat surprising given the similarities in the estimated prevalence of 
current LARC use among women receiving OAT and the general population (18% and 
14%, respectively). If women receiving OAT are managing to use LARCs at a rate similar 
to the general population despite significant deficits in knowledge about these methods, 
one strategy to increase LARC use among women receiving OAT is to promote greater 
knowledge about LARC attributes, efficacy, and use among this population in an effort to 
further increase rates of LARC use.  In fact, a recent study by Kotha et al. (2019) reported 
that increasing knowledge about LARCs via contraceptive counseling increased intention 
to use LARCs postpartum among a large sample of pregnant women receiving OAT. 
Although there are of course discrepancies between LARC intent and subsequent use 
(Ogburn et al., 2005; Engin-Ustun et al., 2007; Chen et al., 2010; Kotha et al., 2019), 
increasing knowledge about LARCs is a first step in promoting their use and should be 
incorporated into family planning interventions in general and may be particularly 
influential in increasing uptake among women receiving OAT. 
Other contraceptive methods knowledge. There was a significant difference 







area (i.e. knowledge about the withdrawal method, male condoms, and emergency 
contraception pills). Patients receiving OAT only answered approximately half of these 
questions correctly, about 15% less than patients receiving PC. This has implications 
clinically. For example, poor knowledge about emergency contraception pills may interfere 
with correct use of this method. Given the overall low rates of contraceptive use among 
individuals receiving OAT (Black et al., 2012; Cornford et al., 2015; Krans et al., 2018), 
use of emergency contraception provides a unique opportunity to prevent pregnancy after 
unprotected intercourse (Trussell et al., 2018). As discussed in the Introduction, the 
colloquial name for emergency contraception, “morning after pill,” may be misleading, 
thereby interfering with optimal use. Misperceptions about the use of emergency 
contraception pills may arise from inaccurate portrayals by various sources, including the 
media and pharmacists, about how emergency contraception pills work and/or their 
availability (Moore, Ryan, & Stamm, 2018; Nelson & Jaime, 2009; Pruitt & Mullen, 2005). 
Consequently, increasing individual knowledge about emergency contraception pills may 
decrease risk of unintended pregnancy by modifying mental short cuts (i.e. heuristics) or 
misinformation individuals reference to inform their contraceptive behavior. 
 
Sex 
In addition to differences between patient samples in the percent of correct 
responses overall and among most of the CKA content areas, the percent of correct 
responses overall and among four of the five CKA content areas also differed by sex. With 
the exception of the “other contraceptive methods knowledge” content area, women 







has historically been focused on women and the majority of contraceptive methods 
available are for use by women, these results were not unexpected. Historically, family 
planning services were focused on the needs of women and failed to incorporate education 
and interventions for men. However, beginning in the mid-1990s, there was an 
international effort by family planning and reproductive health organizations to provide a 
framework for addressing men’s unique reproductive needs and inclusion in family 
planning services (Bustamante-Forest & Giarratano, 2004; Cornwall & White, 2000; 
Drennan, 1998; Sternberg & Hubley, 2004). There is evidence that these efforts are starting 
to have some impact.  For example, the federal Office of Population Affairs and the CDC 
recommend “women and men of childbearing age should have high reproductive 
awareness (i.e. understand factors related to childbearing) and a reproductive life plan” and 
receive family planning services (emphasis added; Gavin et al., 2014). To this end, more 
recent research has demonstrated that male partners believe they should participate in 
decision-making about contraception (Grady et al., 1996; Richards et al., 2016; Stewart et 
al., 2017). Therefore, one strategy to optimize reproductive awareness for men is to 
increase knowledge about ways to prevent unintended pregnancy in general (e.g. 
knowledge about effective use of contraception and fertility awareness) and not just focus 
on contraceptive methods available for men. 
The revised Health Belief Model proposed by Hall et al. (2012) is the only model 
to our knowledge that explicitly includes men as a modifying/enabling factor that can 
influence decisions about contraceptive use. In fact, there is some research that suggests 
among women receiving OAT, a woman’s familiarity with her partner is an important 







majority of men in the US are in need of family planning services (Marcell et al., 2016), 
increasing men’s individual knowledge about contraception and fertility awareness may be 
an important preliminary step to increase contraceptive use and decrease rates of 
unintended pregnancy.  
 
Comparison to Existing Literature 
It was noted in the Introduction that methodological differences made it difficult to 
directly compare the results of the two published quantitative studies of which we are aware 
on contraceptive knowledge among women receiving OAT to each other (Matusiewicz et 
al., 2017; Meschke et al., 2018).  Unfortunately, methodological differences also limit 
comparisons between the present results and these two studies.  More specifically, 
differences in sample population (i.e. a convenience sample of women receiving OAT in 
the present study and the Meschke et al., 2018 study compared to a more restricted sample 
in the Matusiewicz et al., 2017 study), question response format (i.e. five response choices 
vs. true/false), question content, and presentation of results (i.e. overall knowledge vs. 
information about specific content areas), make specific comparisons and contrasts 
exceedingly difficult and are likely not very meaningful. However, it can be said that the 
three studies overall provide consistent evidence of generally moderate levels of 
knowledge about family planning among women receiving OAT.  
   
Study Limitations 
 There are some limitations of this study. First, prior contraceptive use and other 







participant age was examined as a potential covariate and found not to play a role, it is 
unclear if there are other confounding factors associated with patient sample or sex that 
may be influencing family planning knowledge. Thus, future research should examine 
whether these characteristics impact family planning knowledge and behavior. Second, this 
study was not powered to analyze individual items on the CKA. Given the relatively high 
levels of general knowledge about contraception and low levels of knowledge about 
different types of contraception, additional research is necessary to identify the specific 
knowledge deficits of different contraceptive methods. Third, although the five CKA 
content areas were established by expert review, no psychometric evaluation of these areas 
was conducted. Additional analyses (e.g. factor analysis, inter-item correlations) are 
necessary to confirm the construct validity of the content areas to further expand the utility 
of this measure. Finally, it is unclear how generalizable these results are to other 
populations of individuals diagnosed with OUD. Within-group studies are necessary to 
identify family planning knowledge and contraceptive use among different groups of 
individuals with OUD. For example, is family planning knowledge similar among various 
groups of individuals with OUD, or are differences in age, education, treatment status, or 









 Contraceptive use is low (~50%) and unintended pregnancy rates are high (~80%) 
among women receiving OAT. In the absence of basic knowledge about family planning 
it is unreasonable to expect effective use of contraception. The results of this study 
indicate that there are statistically significant differences in family planning knowledge 
between individuals receiving OAT and a comparison sample, but the absolute 
differences were generally small. Therefore, in settings where resources are limited, 
providing women and men receiving OAT with accurate information about family 
planning may lead to small increases in effective use of contraception and small 
decreases in unintended pregnancy. However, to make significant gains in this area, 
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Contraceptive Knowledge Assessment (CKA) 
6.  Which is the only birth control method that helps 
prevent infections? 
a. The birth control pill 
b. Male and female condoms 
c. Depo-Provera (“the shot”) 
d. The IUD (intrauterine device, the “T”) 
e. I don’t know 
12.   What is the main way that birth control works? 
a. It prevents the ovary from releasing the egg (ovulation) 
b. It prevents the sperm from entering the uterus 
c. It prevents the fertilized egg from implanting in the 
utuerus 
d. It prevents the embryo from growing past a certain size 
e. I don’t know 
Note. Correct answers are in bold and italicized. 
  
1.  When during a woman’s cycle is she most likely to 
become   
      pregnant? 
7.    All of the following are TRUE about using male    
       condoms EXCEPT: 
a. During her period (start of her cycle) a.    You should use water-based lubricants with spermicide 
b. 3 days after her period ends b.    Wear two condoms to be extra safe 
c. Two weeks before her next period starts 
d. 3 days before she gets her period (end of cycle) 
c.    Prevent air bubbles by holding the condom tip when    
       putting it on 
e. I don’t know d.    Check the expiration date and keep them in a cool and  
       dry environment (i.e. not in a wallet or in a car) 
 e.    I don’t know 
2.  How long can sperm stay alive in a woman’s body? 
  a.     1-3 hours  
8.    Hormonal birth control comes in which of the     
       following forms? 
  b.     24 hours  a.    Pills taken by mouth 
  c.     3-5 days b.    Patch worn on the skin 
  d.     7-10 days c.    Ring placed in the vagina 
  e.     I don’t know d.    All of the above 
 e.    I don’t know 
3.   Which of the following choices is TRUE about 
pregnancy? 
a. You cannot become pregnant the first time you     
         have sex 
9.    Which one is NOT a benefit of hormonal birth control? 
a.    Improvement of diabetes 
b.    Improvement of acne 
b. You cannot become pregnant if you have sex 
standing up 
c. You cannot become pregnant if you do not have an 
orgasm 
d. None of the above are true 
e. I don’t know 
c.    Reduction in menstrual cramps and bleeding problems  
       like anemia 
d.    Decreased risk of ovarian and uterine cancer 
e.    I don’t know 
4.   Which of the following choices is TRUE about 
withdrawal, or the   
      “pull-out” method? 
10.   How long should the vaginal ring (NuvaRing) stay in  
        place before changing it? 
a. Sperm may be released before ejaculation  a.    1 day 
b. Withdrawal works as well as condoms at 
preventing pregnancy 
c. Withdrawal can protect against some sexually 
transmitted diseases (STDs) 
 b.    1 week 
 c.    3 weeks 
 d.    3 months 
d. Withdrawal works as well as the birth control pill 
at preventing pregnancy  
 e.    I don’t know 
e. I don’t know   
5.   Which birth control method guarantees you will not 
become   
      pregnant? 
11.  Which of the following make hormonal birth control  
        less effective? 
a. None  a.     Seizure (epilepsy) medicine  
b. Using a condom every time you have sex  
c. Douching, showering, or bathing immediately after 
sex 
d. “Pulling out” before ejaculation 
e. I don’t know 
 b.     HIV medicine  
 c.     Herbal supplements 
 d.     All of the above  









Note. Correct answers are in bold and italicized. 
 
13.  Birth control pills can have which of the following ingredients? 
         a.    Testosterone 
19.  Which birth control method is not easily noticed by a  
        partner? 
b.    Estrogen a.    The IUD (intrauterine device) 
c.    Magnesium b.    The vaginal ring 
d.    Calcium c.    Male condom 
e.    I don’t know d.    Female condom 
 e.     I don’t know 
14.  You should NOT use the birth control pill if you have  
       any of the following: 
20.   A provider places an IUD (intrauterine device) in  
         which part of the body? 
a.     Fibroids a.      Fallopian tube 
b.     Drink alcohol b.      Uterus 
c.     Currently taking antibiotics c.      Cervix 
d.     None: it is safe to use the birth control pill in all of  
        these situations 
d.      Vagina 
e.      I don’t know 
e.    I don’t know  
15.  How long after a woman stops using birth control can  
       she become pregnant? 
21.  Which method of birth control is the best at  
        preventing pregnancy? 
a.     Immediately a.     The IUD (intrauterine device) 
b.     1 month b.     Depo-Provera (“the shot”) 
c.     3 months c.     Male condom 
d.     6 months  
e.     I don’t know 
d.     Withdrawal (“pull out method”) 
e.     They are equally effective  
 f.      I don’t know 
16.  If you forget to take one birth control pill and  
        remember the next day, what should you do? 
22.  Which choice is FALSE about IUDs (intrauterine  
        devices)? 
a.    Throw the missed pill away and then continue the 
       following day from where you left off 
b.    Take the rest of the week’s pills at once and then        
       start the placebo (“reminder”) week 
c.    Take two pills then continue 
a.      Women of all ages may get an IUD 
b.      Women who have never had a baby may get an 
IUD 
c.      Women can have an IUD put in right after 
having a baby or having an abortion 
d.    Throw the missed pill away and wait 1 month to   
        start a new pack 
e.    I don’t know 
d.     Women cannot get an IUD if they have ever 
had a sexually transmitted disease (STD) 
e.      I don’t know 
17.  Which of the following is FALSE about Depo-Provera  
       (the “shot”)? 
23.  A provider places the birth control implant  
       (Nexplanon) in what part of the body? 
a.     It is administered every 3 months a.    Thigh 
b.     Gradual weight gain is possible b.    Vagina  
c.     It might take a few months after stopping to become  
        pregnant 
c.     Arm 
d.     Buttock 
d.     It cannot be used while breastfeeding e.     I don’t know 
e.     I don’t know  
18.  Which of the following birth control methods may be  
        reversed if you decide you want to become pregnant? 
24.   How soon after sex must the “morning after pill”   
        (emergency contraception) be used to be effective? 
a.    Tubal ligation (“tying your tubes” or “cutting your tubes”) a.   1 hour 
b.    Essure coils b.   24 hours  
c.    Vasectomy c.    3 days  
d.    IUD (intrauterine device) d.   20 days 
e.    I don’t know e.    I don’t know 
25. How can you get the emergency contraception pill (i.e. the morning after pill)? 
a.   If under 18, you cannot get it, even with a prescription 
b.   If under 21, you must have your parent go with you to  
       the doctor for a prescription 
d.  You can buy it at the pharmacy, without 
      prescription, no matter what age 
e.   I don’t know  






Table 4. Sample Characteristics 
 Overall 







Female Male p 
value 
OAT PC OAT PC 
N=332 n=167 n=165  n=169 n=163  n=85 n=84 n=82 n=81  
Age (mean yrs. ± SE) 32.1 0.3 32.9  0.4 31.3  0.5 <.05 31.2  0.5 33.0  0.5 <.01 32.1  0.6 30.3  0.8 33.8  0.6 32.2  0.7 .89 
Race/Ethnicity (%)    .29   .44     .51 
 White 86 87 85  87 85  88 86 85 85  
 Hispanic/     
    Latino 
2 2 3  2 2  1 4 2 2  
Black/African 
    American 
3 2 5  2 5  1 2 2 7  
Other 8 10 7  9 7  9 8 10 5  
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Interaction: p = .73
Figure 5. Mean Percent Correct on the Contraceptive Knowledge Assessment 
(CKA) by Main Effects of Patient Sample (top left panel) and Sex (top right 
panel) and Interaction (bottom panel). 
 
 
Main effect of sex:  





Table 5.  Responses to Contraceptive Knowledge Assessment (CKA) Content Area Questions  
(Mean % Correct  SE) 
  
 








Female  Male  p 
value 
OAT PC OAT PC 
N=332 n=167 n=165  n=169 n=163  n=85 n=84 n=82 n=81  
Fertility Awareness  
      (3 questions) 
53  1 49  2 58  2 <.01 58  2 48  2 <.01 53  3 62  3 44  2 53  3 .97 
            
General Contraceptive Knowledge  
      (6 questions)  
66  1 62  2 70  2 <.001 70  2 62  2 <.01 67  2 72  3 57  2 68  3 .23 
            
Short-Acting Contraception  
      (9 questions)  
37  1 37  2 38  2 .66 45  2 30  1 <.001 43  2 46  2 30  2 29  2 .48 
            
Long-Acting Contraception 
     (3 questions) 
43  2 38  2 48  3 <.01 53  2 33  2 <.001 49  3 56  3 27  3 39  4 .47 
            
Other Methods  
     (4 questions) 
58  1 53  2 62  2 <.01 59  2 56  2 .28 55  3 63  3 51  3 61  3 .71 
            
Note. OAT: Opioid Agonist Treatment Sample. PC: Primary Care Sample.  p values represent total two-way analysis of variance analysis. 
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